TABLE 3.
Model and factor | Hazard ratio (95% CI) | P a |
---|---|---|
Model A | ||
Age (per 5 yrs) | 1.23 (1.12–1.35) | <0.001* |
Active malignant disease | 1.98 (1.12–3.51) | 0.019* |
Results of BALF mycological tests | 0.62 | |
Negative BALF GM and negative BALF culture | Reference | |
Positive BALF GM and negative BALF culture | 0.90 (0.46–1.76) | 0.77 |
Negative BALF GM and positive BALF culture | 1.30 (0.41–4.14) | 0.66 |
Positive BALF GM and positive BALF culture | 1.39 (0.82–2.37) | 0.22 |
Model Bb | ||
Age (per 5 yrs) | 1.27 (1.14–1.40) | <0.001* |
Active malignant disease | 2.02 (1.11–3.68) | 0.021* |
Results of BALF mycological tests | 0.11 | |
Negative BALF GM and negative BALF culture | Reference | |
Positive BALF GM and negative BALF culture | 1.30 (0.62–2.70) | 0.49 |
Negative BALF GM and positive BALF culture | 1.53 (0.42–5.54) | 0.52 |
Positive BALF GM and positive BALF culture | 2.53 (1.28–5.02) | 0.008* |
*, P < 0.05.
Model B included center as shared frailty.